2020
Systematic review of benzodiazepines for anxiety disorders in late life.
Gupta A, Bhattacharya G, Farheen SA, Funaro M, Balasubramaniam M, Young J, Tampi DJ, Tampi RR. Systematic review of benzodiazepines for anxiety disorders in late life. Annals Of Clinical Psychiatry 2020, 32: 114-127. PMID: 32343283.Peer-Reviewed Educational MaterialsConceptsAnxiety disordersSystematic reviewOlder adultsTolerability of benzodiazepinesCochrane Central RegisterMild adverse effectsLater lifeEnglish-language articlesTreatment of anxietyLong-term useWeb of ScienceTolerability dataCentral RegisterControlled TrialsCochrane DatabaseOvid EmbaseLong-term benefitsOvid MEDLINEInclusion criteriaEligible articlesBenzodiazepinesDecreased anxietyStudy periodAdverse effectsTrials
2019
Antidepressants for anxiety disorders in late-life: A systematic review.
Balasubramaniam M, Joshi P, Alag P, Gupta S, Maher S, Tampi D, Gupta A, Young J, Tampi RR. Antidepressants for anxiety disorders in late-life: A systematic review. Annals Of Clinical Psychiatry 2019, 31: 277-291. PMID: 31369663.Peer-Reviewed Educational MaterialsConceptsLate-life anxietyAnxiety disordersRCTs of antidepressantsCochrane Central RegisterTolerability of antidepressantsBibliographic databases PubMedGeneralized anxiety disorderLong-term useCentral RegisterControlled TrialsAntidepressantsElectronic searchDatabases PubMedSystematic reviewOlder adultsStudy periodTrialsDisordersAnxiety symptomsLater lifeLimited dataSignificant reductionAnxietyReviewTolerabilityANTIDEPRESSANTS FOR ANXIETY DISORDERS IN LATE-LIFE: A SYSTEMATIC REVIEW
Balasubramaniam M, Joshi P, Alag P, Gupta S, Maher S, Tampi D, Gupta A, Young J, Tampi R. ANTIDEPRESSANTS FOR ANXIETY DISORDERS IN LATE-LIFE: A SYSTEMATIC REVIEW. American Journal Of Geriatric Psychiatry 2019, 27: s125. DOI: 10.1016/j.jagp.2019.01.076.Peer-Reviewed Original ResearchSerotonin-norepinephrine reuptake inhibitorsSelective serotonin reuptake inhibitorsUse of antidepressantsTolerability of antidepressantsLate-life anxietySystematic reviewAnxiety disordersOlder adultsReuptake inhibitorsTreatment optionsTricyclic antidepressantsCognitive impairmentFirst-line pharmacological treatmentLate-life anxiety disordersVariable drug absorptionLong-term tolerabilityEfficacy of antidepressantsEfficacious treatment optionSerotonin reuptake inhibitorsPrevention of relapseCochrane Collaboration databasesTrial of paroxetineLate-life GADLater lifeVolume of distribution